FTC sues Martin Shkreli for violating lifetime pharma ban
Statements (10)
- Neutral
Pennsylvania Attorney General wants Martin Shkreli held in contempt for allegedly violating a lifetime pharma ban
- Neutral
FTC accuses Martin Shkreli of violating a lifetime pharma ban
- Bearish
Martin Shkreli is accused of violating the lifetime ban from the drug industry by the U.S. government.
- Bearish
FTC banned Martin Shkreli from trading pharmaceutical stocks for life
- Bearish
The Federal Trade Commission and seven states filed a lawsuit against Martin Shkreli for violating a lifetime ban from the pharmaceutical industry.
- Neutral
FTC says Martin Shkreli violated his lifetime pharma ban
- Bearish
Martin Shkreli is being investigated by regulators for influencing biopharma stocks.
- Neutral
FTC demands Martin Shkreli divest his pharma stocks
- Neutral
Martin Shkreli is in contempt of court after violating a lifetime ban on the pharmaceutical industry.
- Neutral
Shkreli faces contempt for breaking a pharmaceutical industry ban